Skip to main content
Livermore
Livermore
ZHEN

Catalyst Pharmaceuticals, Inc.

CPRXDelisted Jul 15, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001369568

Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 396 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2024 vs. Q1 2024

How the institutions holding Catalyst Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of CPRX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders2682271+5
Shares96.2M146.3K96.9M+833.8K (+0.9%)
Value$1.53B$2.32M$1.50B−$29.9M (−2.0%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (36)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to CPRX in Q2 2024
InstitutionSharesValue% of portfolio
Integral Health Asset Management, LLC275,000$4.26M0.42%
Richard P Slaughter Associates Inc162,203$2.51M0.59%
QSV Equity Investors LLC84,137$1.30M1.36%
Corebridge Financial, Inc.67,330$1.04M0.01%
Mirae Asset Global ETFs Holdings Ltd.63,929$987.1K0.00%
Guggenheim Capital LLC54,129$838.5K0.01%
Balyasny Asset Management LLC51,815$802.6K0.00%
Toroso Investments, LLC40,046$620.3K0.01%
Advantage Alpha Capital Partners LP37,320$578.1K0.13%
Natixis Advisors, L.P.33,146$513.0K0.00%
Brevan Howard Capital Management LP29,808$461.7K0.03%
Verition Fund Management LLC24,055$372.6K0.00%
Gallacher Capital Management LLC18,564$287.6K0.15%
Graham Capital Management, L.P.17,509$271.2K0.01%
Susquehanna Fundamental Investments, LLC16,683$258.4K0.01%
TD Asset Management Inc16,400$254.0K0.00%
Mackenzie Financial Corp14,016$217.1K0.00%
GTS Securities LLC11,845$183.5K0.00%
PVG Asset Management Corp11,786$182.6K0.72%
Sherbrooke Park Advisers LLC11,635$180.2K0.03%
Algert Global LLC10,684$165.5K0.01%
Wolverine Trading, LLC10,609$164.3K0.00%
Creative Planning10,025$155.3K0.00%
Cladis Investment Advisory, LLC10,000$154.9K0.11%
Point72 Asia (Singapore) Pte. Ltd.9,857$152.7K0.03%
Catalyst Funds Management Pty Ltd7,000$108.4K0.03%
Meeder Asset Management Inc4,497$69.7K0.00%
Simplex Trading, LLC2,633$40.0K0.00%
Jones Financial Companies LLLP500$7.75K0.00%
Mather Group, LLC.465$7.41K0.00%
SRS Capital Advisors, Inc.356$5.51K0.00%
Smartleaf Asset Management LLC229$3.44K0.00%
Innealta Capital, LLC162$2.51K0.00%
Larson Financial Group LLC11$1700.00%
Coppell Advisory Solutions LLC8$1240.00%
Planning Capital Management Corp1$160.00%

Sold out (31)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of CPRX in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Hudson Bay Capital Management LP280,000$4.46M
Paradiem, LLC181,295$2.89M
Norges Bank120,000$1.91M
Texas Permanent School Fund97,747$1.56M
ClariVest Asset Management LLC73,967$1.18M
American International Group, Inc.60,087$957.8K
Gsa Capital Partners LLP59,838$954.0K
Capital Impact Advisors, LLC59,577$949.7K
Mirae Asset Global Investments Co., Ltd.57,167$929.5K
Toth Financial Advisory Corp33,800$538.8K
Fox Run Management, L.L.C.27,853$444.0K
Bayesian Capital Management, LP23,400$373.0K
New York Life Investment Management LLC22,640$360.9K
Capstone Investment Advisors, LLC22,616$360.5K
Walleye Capital LLC21,302$339.6K
Campbell & CO Investment Adviser LLC19,202$306.1K
Arrowstreet Capital, Limited Partnership12,921$206.0K
D. E. Shaw & Co., Inc.12,261$195.4K
Cornercap Investment Counsel Inc12,216$194.7K
Two Sigma Securities, LLC12,107$193.0K
Virtu Financial LLC11,978$191.0K
Teza Capital Management LLC11,871$189.2K
Cim Investment Mangement Inc10,888$173.6K
Nebula Research & Development LLC10,703$170.6K
Headlands Technologies LLC9,675$154.2K
Point72 (DIFC) Ltd6,636$105.8K
Metropolitan Life Insurance Co5,867$93.5K
Truvestments Capital LLC391$6.23K
First Manhattan Co250$3.98K
Sofos Investments, Inc.21$342
Northwestern Mutual Wealth Management Co3$48

Not filed for Q2 2024 yet (2)

Institutions that held Catalyst Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CPRX in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG117,399$1.87M
Shell Asset Management Co28,896$448.0K